OCT. 2011

October is American Pharmacists Month

The Official PublicationOf The Florida Pharmacy Association

2 | F l o r i d a P h a r m a c y T o d a y

Alliance for Patient Medication Safety a federally certified patient safety organization (PSO)

Pharmacies that report patient safety events are provided federal legal protection to patient safety information

that is reported through APMS.

Thousands of Medicare Part D pharmacy providers are meeting their QA requirements and getting legal protection of their quality assurance data with the easy to use, low cost Pharmacy Quality Commitment (PQC) program. (PQC) is a continuous quality improvement program that strives to reduce medication errors in the pharmacy by offering structures and methods for improvement and a feedback system that allows the pharmacist to elevate the quality of patient care.

Compounding Adverse Drug Events Reporting (C-ADER) A standardized tool for compounding pharmacies to simply and effectively track and report any adverse events that are potentially associated with compounded medications.

Quality Assurance Reporting Services

BACKGROUND NASPA promotes leadership, sharing, learning, and policy exchange among state pharmacy associations and pharmacy leaders nationwide, and provides education and advocacy to support pharmacists, patients, and communities working together to improve public health. NASPA was founded in 1927 as the National Council of State Pharmacy Association Executives (NCSPAE). APMS, LLC was established in August 2008 by NASPA and was listed in December 2008 as a Patient Safety Organization (PSO) with the Agency for Health Research and Quality (AHRQ). The mission of APMS, LLC is to foster a culture of quality within the profession of pharmacy that promotes a continuous systems analysis to develop best practices that will reduce medication errors, improve medication use and enhance patient care.

Pharmacy and Prescriber E-prescribing Experience Reporting (PEER) Portal A questionnaire/reporting site designed to allow practicing pharmacists and prescribers to share their experiences with e-prescribing technologies. All comments - whether suggestions for improvement or complaints about the process - are welcome. This detailed information gathered can be used to improve the quality and effectiveness of electronic prescribing technologies and overall quality and operation of the e-prescribing infrastructure.

Alliance for Patient Medication Safety www.medicationsafety.org info@medicationsafety.org

866 365-7472

Quality Assurance Reporting to APMS provides federal legal protection to patient safety information. In addition, participating pharmacies will receive recommen-dations on best practices and workflow processes to help reduce medication errors, improve medication use and enhance patient safety and health outcomes.

o c T o B E r 2 0 1 1 | 3

Vol. 74 | No. 10ocToBEr 2011 ThE oFFicial PuBlicaTioN oF ThEFlorida Pharmacy associaTioNP H A R M A C Y T O D A Y

florida

Departments 4 calendar

4 advertisers

5 President’s Viewpoint

7 Executive insight

20 Pharmacy Time capsule

22 Buyer’s Guide

Features

about american Pharmacists month

The Florida Pharmacy association 2011 resolutions

New law impacts Treatment of chronic Nonmalignant Pain

10

11

17

4 | F l o r i d a P h a r m a c y T o d a y

E-mail yOur suggEsTiOns/idEas TO

dave@fiorecommunications.com

Mission Statements:of the Florida Pharmacy Today JournalThe Florida Pharmacy Today Journal is a peer reviewed journal which serves as a medium through which the Florida Phar-macy Association can communicate with the profession on advances in the sciences of pharmacy, socio-economic issues bearing on pharmacy and newsworthy items of interest to the profession. As a self-supported journal, it solicits and accepts advertising congruent with its expressed mission.

of the Florida Pharmacy Today Board of directors The mission of the Florida Pharmacy Today Board of Directors is to serve in an advisory capacity to the managing editor and execu-tive editor of the Florida Pharmacy Today Journal in the establishment and interpreta-tion of the Journal’s policies and the manage-ment of the Journal’s fiscal responsibilities. The Board of Directors also serves to motivate the Florida Pharmacy Association members to secure appropriate advertising to assist the Journal in its goal of self-support.

AdvertisersAlliAnce for

pAtient medicAl sAfety ....................... 2cArdinAl HeAltH ....................................... 15epc ..................................................................... 13HeAltHcAre consultAnts ....................... 3KAHAn ◆ sHir, p.l. ........................................ 15ppsc ..................................................................... 9rx relief ......................................................... 15

2011-2012

FPA Calendar nOvEmbEr

12-13 Board of Directors, Budget and Finance Committee and Council Meetings

11 Veterans Day FPA Offices Closed

17-20 NASPA Fall Meeting

24-25 Thanksgiving FPA Offices Closed

dECEmbEr

3-4 FPA Law Conference Sarasota, Florida

13-14 Florida Board of Pharmacy MeetingGainesville, Florida

23 & 26 FPA Office Closed for Holidays

January 2012

2 FPA Office Closed for New Year’s Day

10 Legislative Session Begins

16 FPA Office Closed for Martin Luther King’s Birthday

20 Journal Board Conference Call

24-25 Pharmacy Days at the Florida Capitol

25 Florida Pharmacy Health Fair at the Florida Capitol

28 - 29 FPA Law and Consultant ConferenceSandestin

31 Deadline for the submission of FPA Election Ballots

CE CrEdiTs (ce cycle)the florida Board of pharmacy requires 10 hours liVe continuing education as part of the

required 30 hours general education needed every license renewal period.pharmacists should have satisfied all continuing education requirements for this biennial

period by september 30, 2011 or prior to licensure renewal.*for pharmacy technician certification Board Application, exam information and study

materials, please contact ranada simmons in the fpA office.for more information on ce programs or events:contact the florida pharmacy Association at (850) 222-2400 or visit our Web site at www.

pharmview.com

COnTaCTsfpA — michael Jackson (850) 222-2400fsHp — michael mcQuone (850) 906-9333u/f — dan robinson (352) 273-6240fAmu — leola cleveland (850) 599-3301nsu — carsten evans (954) 262-1300

disClaimEr Articles in this publication are designed to provide accurate and authoritative information with re-spect to the subject matter covered. this information is provided with the understanding that neither florida pharmacy today nor the florida pharmacy Association are engaged in rendering legal or other professional services through this publication. if expert assistance or legal advice is required, the services of a competent professional should be sought. the use of all medications or other pharmaceutical products should be used according to the recommendations of the manufacturers. information provided by the maker of the product should always be consulted before use.

For a complete calendar of events go to www.pharmview.com

o c T o B E r 2 0 1 1 | 5

In my opinion, the laws and rules that impact the practice of pharmacy are the

basis for determining what a reasonable

and prudent person would do.

Pharmacists are asked to engage in complex and unpredictable tasks on society’s behalf on a

daily basis. In the practice of pharma-cy, pharmacists routinely exercise dis-cretion. We make judgments based on what is best for the patient, rather than what may necessarily be “right” in some absolute sense.

Many times these situations cannot be seen as black or white. Inevitably, some of these judgments lead to “er-ror,” which is endemic to professional practice. At the foundation of profes-sional judgment is a form of knowledge — called practical wisdom — which is not formally taught and learned but is acquired largely through experience and informal conversations with re-spected peers.

Professional judgment is often de-scribed as “what would a reasonable and prudent pharmacist do under sim-ilar circumstances.” Wisdom develops through “the critical reconstruction of practice,” including deliberation, which is distinguished from mere reflection. This deliberation includes interaction with other health care providers, not just pharmacists.

The phrase “professional judgment” can be found many times in Florida laws and rules. 465.003 (6) defines the act of dispensing and says: As an ele-ment of dispensing, the pharmacist shall, prior to the actual physical transfer, inter-pret and assess the prescription order for potential adverse reactions, interactions, and dosage regimen she or he deems ap-propriate in the exercise of her or his pro-fessional judgment... This is just one of many instances where this important element of our professional practice is addressed in the laws that directly im-

pact the practice of pharmacy.Why is this important for us to con-

sider in all that we do for our patients? The Florida Pharmacy Practice Act

tells us: “465.002 Legislative findings; intent. —- The Legislature finds that the practice of pharmacy is a learned profession.” As a learned profession,

there is a higher level of responsibility that we as pharmacists are expected to provide to the citizens of Florida who rely on our expertise for their health care. We are expected to provide coun-seling. We have a duty to warn the pa-tient if we recognize a potential for an adverse drug event. The license that we hold is a privilege to practice pharma-cy and not a “right.” We have to real-ize that this privilege to hold a license to practice pharmacy can be taken from

us if we do not uphold the highest stan-dards of practice and use our “profes-sional judgment” only in the best inter-ests of our patients.

On what should we base our “pro-fessional judgment?” As I stated earli-er, your actions will be judged by the question “what would a reasonable and prudent pharmacist do under similar circumstances?”

In my opinion, the laws and rules that impact the practice of pharmacy are the basis for determining what a reasonable and prudent person would do. Realizing that everything is not al-ways black or white when it comes to law, your education, experience and training will be key in making your de-cisions. It is in these “gray” areas that your “professional judgment” will be the determining factor in your deci-sion. A solid knowledge of the laws and rules that relate to pharmacy will help you develop the basic element of

The Value of Professional Judgment

The President’s ViewpointbOb ParradO, FPa PrEsidEnT

bob Parrado, 2011-2012 FPa President

6 | F l o r i d a P h a r m a c y T o d a y

professional judgment. Having to take a test on the laws and rules as a require-ment for licensure establishes the fact that you are required to know these laws and rules. This pertains to feder-al laws also.

In the DEA Pharmacists Manu-al, (which is available as a link in the member’s section of www.pharmview.com), the concept of “Corresponding Responsibility” is explained. It says that a pharmacist has a corresponding responsibility to ensure the validity of a prescription before that prescription can be dispensed. By knowing that this law is considered a standard of practice, it would be difficult for a pharmacist to say, “In my professional judgment, be-cause the physician wrote the prescrip-tion, I can fill it without question.”

Another example would be a phar-macist making the statement, “In my professional judgment, I felt it was ap-propriate for my technician to counsel the patient because I was busy and it was a simple answer.” 64B16.27.1001 (1) (f) tells us that only a pharmacist or a pharmacy intern under the direct and immediate supervision of a pharma-cist may counsel a patient. These are just two examples of how the laws and rules establish a standard of care that we must adhere to.

The privilege of having a license to practice pharmacy requires us to use our “professional judgment” when dis-pensing medications to our patients. You may be called on to defend your professional judgment either before the Board of Pharmacy or during a civil lit-igation. You should base your “profes-sional judgment” on the laws and rules that regulate the profession in conjunc-tion with your education, training and experience and your belief that you are acting in the best interests of the pa-tient.

The Florida Pharmacy Association offers continuing-education programs that concentrate on the laws and rules regulating the practice of pharmacy. I encourage you to attend one of these conferences to update your knowledge of the constantly changing legislation that affects our practice on a daily ba-sis. n

The Florida Pharmacy Association gratefully acknowledges the hard work and dedication of the following members of the FPA leadership who work deligently all year long on behalf of our members.

Humberto Martinez ............................................................ Chairman of the BoardRobert Parrado .........................................................................................FPA PresidentGoar Alvarez .............................................................................................. President ElectBetty Harris ............................................................................................................TreasurerSuzanne Wise ...........................................Speaker of the House of DelegatesEric Alvarez ....................................Vice Speaker of the House of DelegatesPreston McDonald, Director ...........................................................................Region 1Marcus Dodd-o, Director .................................................................................Region 2Eva Sunell, Director .............................................................................................Region 3 Raul N. Correa, Director ...................................................................................Region 4 Jeffrey Parrado, Director ..............................................................................Region 5 Chris Lent, Director ..............................................................................................Region 6Paul Rohrbaugh, Director ................................................................................. Region 7Raul Gallo, Director ................................................................................................Region 8Paul Elias, Director ................................................................................................Region 9Venessa Price ......................................................................................... President FSHPMichael Jackson .......................................Executive Vice President and CEO

Florida Pharmacy Today Journal board

Chair......................................................Jennifer Pytlarz, jlc_rxdoc@hotmail.comVice Chair ........................................................ Don Bergemann, don@bceinfo.comTreasurer ...................Stephen Grabowski, sgrabowski@seniormmc.comSecretary ..................................................................Stuart Ulrich, Stuarx@aol.comMember ................................................Joseph Koptowsky, docjik1215@aol.comMember .......................Rebecca Poston, rebecca_poston@doh.state.fl.usExecutive Editor ...............Michael Jackson, mjackson@pharmview.comManaging Editor ..................Dave Fiore, dave@fiorecommunications.com

2011/2012 FPa board of directors

o c T o B E r 2 0 1 1 | 7

For the past 14 years, I have shared information on a host of issues of interest to the membership. It

seems that we never run short of things to talk about, including but not lim-ited to items that can help pharmacy grow as well as the challenging things that create patient-care barriers. The re-sources that the FPA invests in making sure that your voice is heard are signif-icant.

Advocacy is not something that you toss a few dollars at and think the job is finished and everything goes accord-ing to plan. It is actually something that requires an ongoing commitment and stakeholder investment. Any idea what would happen if your light bill is not paid or a past due mortgage is ig-nored? The consequence is not some-thing that any of us would want to have to deal with. I have come to know and realize that advocacy is not much different than any other reoccurring expenses associated with life.

Consider that the profession and business of pharmacy exists primar-ily because of advocacy and the in-vestments made by our predecessors many years ago. They dreamed up the unpopular notion that only a licensed pharmacist should practice that profes-sion, and that these services can only be done within a facility that is regis-tered and recognized by a government-created oversight board (Florida Board of Pharmacy). This new trend of leaner, more efficient government means that all aspects of health care policymak-ing will be reviewed to see if there is a need for oversight boards in today’s health care provider market place. This means that each of us must look at what we do and the services that we

provided to see if society can somehow manage to survive without our busi-ness and professional model.

If you asked yourself whether or not what you do is at risk for obsolescence, then you need advocacy. If someone or something else is in control of what you get paid, what professional servic-es you provide and what you are per-mitted to do with your profession and

your business practice, then you need advocacy. If you cannot identify at least 100 consumers of your services will-ing to take a bullet or go to the wall to ensure that you remain their provid-er, then you need a lot of advocacy. If you are disenchanted with what you do and want a change, then you need advocacy. If your perception of quality services and positive outcomes is con-sidered overrated by others, then you

need advocacy. If you do not know who your state legislator or congressman is, then you need to know about advoca-cy. If your congressman or your state legislator does not know who you are, then you are at serious risk and you must have advocacy. If you are just be-ginning your professional career, you need some serious advocacy. If you are at the end of your professional ca-reer then do you believe that advoca-cy is important to you? Well, sad to say if you want to have control of the life-time of wealth that you created during your labor-intensive years, then you better find out how to be an advocate and work with our young practitioners. If our new practitioner advocacy efforts are not successful, then those making health care policy are coming after you.

The Florida Pharmacy Associa-tion has been intimately involved in this thing called advocacy for a num-ber of years. In recent years, our efforts have been intensive due to the increas-

Executive Insightby miChaEl JaCksOn, rPh

Can You Afford Not to be an Advocate?

by miChaEl JaCksOn, FPa ExECuTivE viCE PrEsidEnT/CEO

michael Jackson, b.PharmAdvocacy is not something that you toss a few dollars at and think the

job is finished and everything goes

according to plan.

8 | F l o r i d a P h a r m a c y T o d a y

ing number of challenges we are fac-ing both at the federal and state lev-els. As your association manager, I am happy to say that our work is be-ing recognized by our membership as important. It is exciting to hear our card-carrying members acknowledge their appreciation for what we have been doing. With over 3,500 members, most are advocate believers. Some are even activists themselves and give their time and talent to fight against

efforts to make poor health care policy. Others have been vocal proponents of FPA-facilitated policy designed to im-prove pharmacy services and advance our profession and business. Consider the following issues and the response from our membership:

mandatory mail Order issuesDuring the 2010 legislative ses-

sion, health care policymakers insert-ed into the state budget a program that would have moved a significant number of chronically diseased Med-icaid recipients into a mail-order pro-gram. On your behalf, FPA leadership quickly moved into an offensive pos-ture and ordered the FPA to file a pe-tition against the state to prevent this program from moving forward. The FPA moved forward with this petition, even though it did not have a defense fund account to offset litigation costs.

Association leadership traveled throughout the state describing the Medicaid bid protest effort and asked for support from membership to help with the expenses. The member-

ship (especially our independent col-leagues) overwhelmingly supported our fight and helped us to raise over $80,000, which we placed into a re-stricted fund account to use exclusive-ly for this effort. The petition filed on behalf of the FPA and one of our mem-bers from Northwest Florida resulted in the state suspending efforts to im-plement the mail-order program.

During the 2011 legislative ses-sion, members of the House and Sen-

ate revisited this issue and revised the language making it optional for the mail-order program to move forward. This change resulted in this particu-lar mail-order program being indefi-nitely suspended and is considered an achieved objective of the FPA on be-half of our membership.

Our combined litigation and pub-lic policymaking advocacy efforts and the inability to take the case to court on the basis of our complaint has re-sulted in a reserve amount balance re-maining in the restricted defense fund account. Your FPA Board of Directors has elected to leave these funds in the restricted account to address future le-gal pharmacy services defense issues. As you are aware, the Medicaid pro-gram is moving entirely to managed care organizations. Florida state em-ployees are also required to get their prescriptions filled through the mail. We will be considering our offensive options as these programs move for-ward.

There is a cost to managing a com-prehensive advocacy program. Mem-

Executive Vice President/CEOMichael Jackson

(850) 222-2400, ext. 200Director of Continuing Education

Tian Merren-Owens, ext. 120Controller

Wanda Hall , ext. 211Membership Coordinator

Ranada Howard, ext. 110 Educational Services Office Assistant

Stacey Brooks , ext. 210

FlOrida PharmaCy TOday bOardChair............................................. Jennifer Pytlarz, BrandonVice Chair ..................Don Bergemann, Tarpon SpringsTreasurer ..............................Stephen Grabowski, TampaSecretary ........................Stuart Ulrich, Boynton BeachMember .................................... Joseph Koptowsky, MiamiMember .............................Rebecca Poston, TallahasseeExecutive Editor ........Michael Jackson, TallahasseeManaging Editor ........................Dave Fiore, Tallahassee

This is a peer reviewed publication. ©2011, FLORIDA PHARMACY JOURNAL, INC.

ARTICLE ACCEPTANCE: The Florida Phar-macy Today is a publication that welcomes articles that have a direct pertinence to the current practice of pharmacy. All articles are subject to review by the Publication Review Committee, editors and other outside referees. Submitted articles are received with the understanding that they are not being considered by another publication. All articles become the property of the Florida Pharmacy Today and may not be published without written permission from both the author and the Florida Pharmacy Today. The Florida Pharmacy Association assumes no responsibility for the statements and opinions made by the authors to the Florida Pharmacy Today.

The Journal of the Florida Pharmacy Association does not accept for publication articles or letters concerning religion, politics or any other subject the editors/publishers deem unsuitable for the readership of this journal. In addition, The Journal does not accept advertising material from persons who are running for office in the association. The editors reserve the right to edit all materials submitted for publication. Letters and materials submitted for consideration for publication may be subject to review by the Editorial Review Board.

FLORIDA PHARMACY TODAY, Annual sub-scription - United States and foreign, Indi-vidual $36; Institution $70/year; $5.00 single copies. Florida residents add 7% sales tax.

Florida Pharmacy association

610 N. Adams St. • Tallahassee, FL 32301850/222-2400 • FAX 850/561-6758

Web Address: http://www.pharmview.com

FPA STAFF

With over 3,500 members, most are advocate believers. Some are even activists themselves and give their

time and talent to fight against efforts to make poor health care policy.

o c T o B E r 2 0 1 1 | 9

I n d e p e n d e n t … B u t N o t A l o n e .P P S C i s Y o u r P a r t n e r f o r S u c c e s s

IncreaseProfits

Every day, pharmacies depend on PPSC to simplify purchasing, reduce costs and identify new revenue sources – making a significant impact on their bottom line.

PPSC can help you:EXPAND use of high-profit genericsCREATE effective store layoutENHANCE third-party profitsCAPTuRE MTM revenue EsTAblisH new business nichesINCREASE your overall margins

For more on how PPSC can maximize the potential of your independent pharmacy, visit www.ppsconline.com or call toll-free 888-778-9909.

bers may ask where their dues and support for the PACCE are going in support of our advocacy efforts. Well, you may be interested in knowing that dues paid to the FPA cover only about 25 percent of FPA’s operating expens-es. Nearly half of the dues that you pay are used to offset our comprehen-sive lobbying effort. The FPA has been resourceful in finding other revenue to support our educational programs and member services. Over 91 percent of the PACCE support received by the FPA from the membership goes to po-litical candidates who are supportive of pharmacy issues. The other 9 percent is used for PACCE printing, publishing and other direct fundraising expens-es. The vast majority of these political campaigns supported by the PACCE were either retained or elected to office.

While the member support of the PACCE, our legal defense fund and the FPA in general during recent months has been phenomenal, additional re-sources are needed. Over 50 percent of the services provided by pharmacists

are paid for by the federal government. The FPA does not only have to monitor what our state legislators are doing, but we also have to help support our na-tional associations. All of you reading this article are advocates in some way. There are thousands of pharmacist and pharmacy technicians who have skin in this advocacy game that are not reading this journal and are not aware of the things that we take for granted as common knowledge.

The sheer scope of questions that we receive in the FPA office from non-member pharmacists overwhelmingly suggests that many within our indus-try do not understand what is happen-ing to them. They come to realize how important being an advocate is after the deed is done and you have adapt-ed while they have not. With the next pharmacist or pharmacy technician you talk to today, ask if they hold ac-tive membership in the FPA and if they are an advocate for their profession or their business. Statistically, it is very possible that who you talk to is not an

active member and is not at the advoca-cy table. October is American Pharma-cists Month. Let’s use this campaign to help others become advocates. If we all do not become involved, the cost of ad-vocacy will only increase with the ve-racity of the issues growing in front of us. n

Florida Pharmacy AssociationLaw and Regulatory Conference

December 3 - 4, 2011Hyatt Regency Sarasota1000 Blvd of the ArtsSarasota, Florida 34236For more information visit www.pharmview.comNOTE: Room reservation cutoff date is November 11, 2011

10 | F l o r i d a P h a r m a c y T o d a y

“We need to promote the pharmacy profession! No one understands what pharmacists do.” How many times have you heard these comments… or even made them yourself? No matter when you first heard the comments, it was not a new idea. Pharmacists have been call-ing for recognition of pharmacists since the profession was established.

William Procter, Jr., a founding member of the then-American Phar-maceutical Association (APhA) ob-served in 1867, that “public opinion is in America a forceful agent of reforms, and has been the main source of prog-ress in pharmacy.” But it wasn’t un-til Asheville, N.C. pharmacist Robert J. Ruth introduced the idea of highlight-ing the profession through an annual celebration that the event took shape. At the 1924 annual meeting, Ruth unveiled his plan of “A National Pharmaceutical Week” and with that the first Nation-al Pharmacy Week was born. The first celebration was held on October 11-17, 1925. During this inaugural effort, ra-dio stations across the country broad-cast special programs which empha-sized the professional side of pharmacy.

A 1959 National Pharmacy Week press kit, found in the APhA News-room during a move to our temporary headquarters, highlighted many of the same issues we talk about today: phar-macy careers, medication costs, and standards for training. Offering practic-ing pharmacists displays, posters, radio and television material, newspaper ar-ticles and even speeches (a complete kit cost $2.00) to ‘promote’ the profession, much like the promotions available on pharmacist.com today. In fact, a current APhA consultant, George B. Griffenha-gen, was on the public relations com-mittee at that time.

After celebrating National Pharma-cy Week for nearly eight decades, 2004 marked the launch of American Phar-macists Month. The expansion to a month responded to APhA member comments that a week was not enough

time to fully promote the expanding role of the pharmacist. And while the length of time was changed, the goal of the event has remained the same: to highlight the importance of the phar-macists’ value to the healthcare system and their role as medication experts.

Since then, American Pharmacists

Month has continued to grow. In 2005, U.S. President George W. Bush ac-knowledged the important role phar-macy professionals play in the lives of Americans. An increasing number of state pharmacy associations, pharma-cists and pharmacy practices partici-pate in the annual celebration.

About American Pharmacists Month

During this inaugural effort, radio stations across the country broadcast special programs which emphasized the professional side of pharmacy

source: aPha

The Florida Pharmacy Association 2011 ResolutionsPresented to the house of delegates

Greetings members of the Florida Pharmacy AssociationThe Florida Pharmacy Association is an advocacy organization whose mission includes the representation of stake-holder members from various professional practice and business interests. We gather at our regional and annual con-ferences to network and exchange ideas that help to facilitate quality patient care and sound business practices. Each year our affiliated and invited organizations identify and send to the annual meeting representatives to review draft policy statements and shape the initial advocacy plan for our professional organization. This is the opportunity for each of you to have input in how the FPA responds to issues.

This summer we met at the Turnberry Isle Resort and debated seven resolutions on various pharmacy issues. Three of the seven were submitted after the deadline and required special handling by the House of Delegates. I have included in this report the results of those deliberations and which of FPA's Committees and Councils are tasked with planning for execution of these policy statements. Some of the resolutions may see immediate action while other issues may re-quire resources and time to achieve its objectives. In either case a final report of the outcome of each of this year's reso-lutions will be reported back to the House of Delegates within three years as defined by Association policy. Watch for my final report next spring on the status of the 2011 resolutions. If there is an interest in discussing an issue, consider working with one of your local associations and plan to submit a resolution at next year's convention in Marco Island. The deadline for the submission of resolutions is March 15, 2012. A resolutions form is included in this issue of Florida Pharmacy Today.

I am also pleased to report the following members of the 2011 - 2012 FPA House of Delegates Board of Directors

Chairman of the House Board of Directors ............................................................................................................ William RiffeeVice Speaker ....................................................................................................................................................................... Eric AlvarezDirector ....................................................................................................................................................................... David MackareyDirector ......................................................................................................................................................................Kimberly Murray Director .......................................................................................................................................................................... Caridad FerreeParlimentarian ....................................................................................................................................................................Lori WeemsFPA President Elect and Ex Officio Member of the Board of Directors ............................................................... Goar AlvarezSecretary of the House .............................................................................................................................................. Michael Jackson

I thank you for allowing me the honor of serving our grassroots organizations on the FPA Board of Directors. Please let me know if I may be of service.

With kindest regards,Suzanne Wise2011 - 2012 Speaker of the House of Delegates

12 | F l o r i d a P h a r m a c y T o d a y

2011 LIST OF RESOLuTIOnS

1. Medical MarijuanaBroward County Pharmacy Association

2. Florida licensed consultant pharmacist to inspect pain management clinics for compliance.Broward County Pharmacy Association

3. Information on the Face of the PrescriptionInteramerican Pharmacists Association 4. Electronically Signed Prescriptions FS 456.42Interamerican Pharmacists Association

Resolutions submitted late:

5. Pharmacist to Intern RatioPalm Beach County Pharmacy Association

6. Encouraging the use of NPI numberProfessional Affairs Council Chair 7. Third Party Prescription Signature RequirementsDade County Pharmacy Association

1 Medical MarijuanaBroward County Pharmacy Association

WHEREAS it has been documented and approved for use in California and neighboring states the medical use of marijuana. There are similar laws under consideration in the Northeastern States.

WHEREAS referencing California SB 420 the following conditions are deemed appropriate for the use of Medical Marijuana: Acquired

immune deficiency syndrome (AIDS), Anorexia, Arthritis, Cachexia, Cancer, Chronic pain, Glaucoma, Migraine, Persistent muscle spasms, including, but not limited to, spasms associated with multiple sclerosis, Seizures, including, but not limited to, seizures associated with epilepsy and Severe nausea.

Therefore BE it RESOLVED: That any Florida legislation related to the legal use of medical marijuana shall include provisions that dispensing and monitoring of such legal use of medical marijuana be managed by Pharmacies, Pharmacists, and Consultant Pharmacists.

Contact:David Andrews PD CPhChairman of the Board, BCPA954-328-4320

Problem: Marijuana has been shown to be effective in treating multiple medical conditions. Unfortunately because of its misuse has been classified as a Schedule I Controlled Substance. This carries in the State of Florida a Felony charge.

Intent: To follow in the regards of other states and decriminalize the use of medical marijuana and make it available on prescription at the pharmacy level.

Motion to amendResolution amendedDivision of the House Called on final VoteResolution fails on standing voteFiscal Impact Statement: $$

2 Florida licensed consultant pharmacist to inspect pain management clinics for compliance.Broward County Pharmacy Association

WHEREAS SB 2272 regulating pain management clinics registered with the Agency for Health Care Administration (AHCA) has been

enacted, and

WHEREAS a provision of this law (458.3265 (3)) calls for routine inspections of pain management clinics by inspectors from the Florida Department of Health (DOH), and

WHEREAS inspectors from the DOH are also charged with other functions including, but not limited to, inspecting pharmacies and dispensing physicians offices

THEREFORE BE IT RESOLVED that FPA, through the FPA Legislative Committee, seek legislation requiring Florida licensed consultant pharmacists to conduct monthly reviews of all registered pain management clinics to ensure compliance with applicable law, regulation and any applicable clinic policy and procedures

Contact:Gary Koesten, M. S., C.Ph.President Elect, BCPA954-979-5995 x 8510

Problem:Manpower issues related to inspecting permit premises do not allow for timely inspections.

Intent:To utilize Florida licensed consultant pharmacists in the inspection process as pertains to registered pain management clinics only

Substitute resolution accepted by sponsorResolution adoptedReferred to Professional Affairs

Fiscal Impact Statement: $$$$$

3Information on the PrescriptionInteramerican Pharmacists Association

Whereas, FS 893.04 states that certain information must appear on the face of the prescription.

o c T o B E r 2 0 1 1 | 13

PHARMACY CONSULTING AND STAFFING SOLUTIONS

Empire Pharmacy Consultants305-374-1029 office305-357-6983 faxinfo@epcepc.com

www.epcepc.com

• Part-time, Full-time, Temporary and Vacation Coverage

• Pharmacy Management Programs

• Open a Pharmacy

• EPC is Pharmacist Owned and Operated

• NO ONE CAN PROVIDE BETTER SERVICE

JOIn TODAY!

Florida Pharmacy Association

Whereas, third party payors are using this FS to deny payment when this information does not appear on the face of the prescription.

Whereas, BOP inspectors are using this FS to cite pharmacies for not having this information on the face of the prescription.

Let it be resolved, that the FPA pursue the change of this FS to remove the wording “on the Face of the Prescription”.

Problem: Several pharmacies are being charged back for thousands of dollars for not having the required information on the face of the prescription. Also, new BOP inspectors are following the letter of the law and citing pharmacies for not having the required information on the face of the prescription.

Intent: To alleviate citations from the BOP from new inspectors for this obscure law. And to stop predatory

audits from third party payors using this FS.

Contact:For more information:Raul Gallo- President IPArigrph@aol.com

Substitute resolution presented by sponsorResolution adopted with no objectionReferred to Governmental Affairs

Fiscal Impact Statement: $$

4Electronically Signed Prescriptions FS 456.42Interamerican Pharmacists Association

Whereas, several prescribers are now using new computer programs that generate electronic signature prescriptions.

Whereas, prescribers are not aware that they must transmit these electronically generated signature prescriptions to the pharmacy and not give them to the patient.

Whereas, pharmacists are not aware that these electronically generated signature prescriptions must be transmitted to the pharmacy and not given to the patient.

Whereas, third party payors are denying payment for these electronically signed prescriptions that are not transmitted to the pharmacy and given to the patient.

Let it be resolved, that the FPA educate both the prescriber and the pharmacist that electronically generated and signed prescriptions must be transmitted to the pharmacy or hand signed by the prescriber, for them to be valid.

Problem: More prescribers are using these new programs with

14 | F l o r i d a P h a r m a c y T o d a y

This award recognizes a pharmacist who has demonstrated excellence in community-based prescription drug abuse prevention. We celebrate Robert’s outstanding efforts and commitment to raising awareness of the dangers of prescription drug abuse among the general public and among the pharmacy community.

For more information about the award, visit cardinalhealth.com/GenerationRx

The Florida Pharmacy Association and the Cardinal Health Foundation congratulate Robert S. Miller as the recipient of the 2011 Cardinal Health Generation Rx Champions Award!

© 2010 Cardinal Health. All rights reserved. CARDINAL HEALTH, the Cardinal Health LOGO, and Essential to care are trademarks or registered trademarks of Cardinal Health. All other marks are the property of their respective owners. Lit. No. 5CR7308 (09/2011) – FL cardinalhealth.com/GenerationRx

o c T o B E r 2 0 1 1 | 15

CONTROL YOUR ASSIGNMENTS,CONTROL YOUR CAREER

The Alternative To A Traditional Career In Pharmacy

Career n.an occupation undertaken for a significant period of a person’s life, usually with opportunities for progress.

• Guaranteed Hours • Professional Pay & Benefits• Special Clients, Flexible Assignments• A Variety Of Bonus Programs• Professional Development Opportunities/Cross Training

Professional Well-Managed Fair

04480 Hensley/RX ReliefFlorida Pharmacy Today—1/4 pg ad (3.5”x4.75”)

A PhArmAcist And A LAwyer

Board of Pharmacy Licensure Disciplinary ProceedingsChapter 499 Violations, Pharmacy Audit Disputes

Mergers and AcquisitionsCommercial, Civil and Criminal Proceedings

KAHAN ◆ SHIR, P.L.

Pharmacist AttorneyBrian A. Kahan, R.Ph., J.D.

Licensed Florida Pharmacist and Attorney

STATEWIDE REPRESENTATION

561-999-5999bkahan@kahanshir.com

1800 N.W. Corporate Blvd., Suite 200 Boca Raton, FL 33431

The hiring of a lawyer is an important decision that should not be based solely upon advertisements. Before you decide, ask us to send you free written information about our qualifications and experience.

electronically signed prescriptions and giving them to the patient without transmitting them to the pharmacy and or not hand signing them.

Intent: To avoid charge backs from third party payor plans for not following this letter of the law.

Contact:Raul Gallo- President-IPArigrph@aol.com

Resolution adopted with no objectionReferred to Public Affairs

Fiscal Impact Statement: $$

RESOLUTIONS SUBMITTED LATE

5*Late Resolution*Pharmacist to Intern RatioPalm Beach County Pharmacy Association

Whereas, the current rules of the Board of Pharmacy require a preceptor to intern ratio of one to one. And

Whereas, there are situations when a preceptor takes both IPPE (Introductory Pharmacy Practice Experience) and APPE (Advanced Pharmacy Practice Experience) and due tothe nature of the scheduling there schedules overlap and there is only one pharmaciston duty. And

Whereas, this puts the preceptor in violation of Board Rules.

Therefore be it resolved, that the Florida Pharmacy Association work with the Florida Board of Pharmacy to change the rule to remove a preceptor to intern ratio

Problem: Because an APPE student is required to attend a 40 hour week they generally are on 8 hour cycles

and the IPPE student depending on the college is required to attend either a 4 of 6 hour shift once a week. The pharmacists in a schedule generally only have a one or two hour overlap. This leaves a number of hours where there is a potential for a pharmacist to be in violation of this rule.

Furthermore, I have found it to be very beneficial for the students to interact with each other and we all learn more. And isn’t that the purpose of internships. Contact:Paul Ackermanpackerman@prodigy.net

Rules of the House suspended to consider this item of new businessMotion to table until the afternoon sessionSecond session of the House convenesMotion to amendMotion to refer to the Professional Affairs Council

16 | F l o r i d a P h a r m a c y T o d a y

Motion to refer adopted

Fiscal Impact Statement: $

6*Late ResolutionEncouraging the use of NPI numberProfessional Affairs Council Chair

Whereas, the National Provider Identification number (NPI) is to be used for identification of professional services, and

Whereas, pharmacists can have NPI numbers to bill for professional services, and

Whereas, most pharmacy professional fees are usually bundled into the price of medications,

Be it resolved that the FPA seek legislation that payment for medications be composed of three components: professional fee, dispensing fee and cost of the medication and,

Be it further resolved, that the FPA seek legislation that adds a professional fee for prescription medications dispensed and,

Be it further resolved, that the professional fee be associated with and payable to the pharmacist’s NPI number.

Problem:The typical method of billing for prescription medications bundles all professional fees into one dispensing fee. This method of payment for health care professional services is not consistent with other health professionals’. Pharmacists’ professional services should be clearly billed for, separate and distinct from the price of drugs and their associated carrying costs.NPI numbers for pharmacists are currently not widely held by individual pharmacists and are not used in the health care billing system to identify the services provided by these pharmacists.

Intent:Separating out the professional pharmacy services fee from the dispensing fee and then linking that fee to the pharmacist’s NPI number brings the billing of these services in line with other health professionals providing care to Florida residents. Eventually, NPI numbers and fees will be built to address pharmacy services not linked to a product (such as MTM, OTC recommendations, etc.).

Contact:Eric Alvarez305-965-7886Chairman- Professional Affairs Council

Motion to suspend the rules of the HouseRules of the House suspendedResolution adopted Referred to the Governmental Affairs Committee

Fiscal Impact Statement: $$$$

7 *Late ResolutionThird Party Prescription Signature RequirementsDade County Pharmacy Association

Whereas there are laws in the State if Florida that explicitly state the requirements of a prescription for controlled and non-controlled drugs, and,

Whereas third party payers are using these prescription requirements to audit pharmacies to reverse payments and

Whereas pharmacies who have been audited have been subject to substantial fees and paybacks to third party payers,

Be it resolved that the Florida Pharmacy Association mount an educational campaign aimed at reinforcing the legal requirements of a prescription, sharing anecdotal events from those who have been subject to a third party audit, and

otherwise educating pharmacists as to the alternatives available to convert invalid prescriptions into valid prescriptions,

Further be it resolved that the Florida Pharmacy Association generate educational letters regarding the legal requirements of a prescription to physicians and that these letters be made available to members of the Florida Pharmacy Association.

Motion to suspend the rules of the HouseRules of the House suspendedQuestion called to end debateResolution adoptedReferred to the Public Affairs Council

Fiscal Impact Statement: $

Fiscal Impact Statement Key:Should address the anticipated costs and benefits that will be derived should the resolution be passed

$ - Minimal to low Impact (Example: Publishing position statements)$$ - Low to Moderate Impact (Example: FPA preparing letters and op-ed papers to policy makers)$$$ - Moderate to Considerable (Example: FPA having to support comprehensive legislative campaign)$$$$ - Considerable to substantial (Example: FPA having to fund consultant assistance, support comprehensive legislative campaign)$$$$$ - Substantial Impact (Consist of FPA spending considerable resources on consultant assistance, funding comprehensive legislative campaigns, and invest in market outreach)

o c T o B E r 2 0 1 1 | 17

In the May 2011 issue of FPA’s Stat News and also the June 2011 issue of Florida Pharmacy Today we briefly re-ported how House bill 7095 affected the prescribing of controlled substances used to treat pain. This new Florida law was created under F.S. 456.44 affecting the regulation of professions in gener-al. Of interest to FPA members is a sec-tion of the law that creates a standard of practice for the treatment of “chron-ic nonmalignant pain” by prescrib-ing practitioners who do not hold cer-tain credentials. Chronic Nonmalignant pain is defined in F.S. 456.44 as pain un-related to cancer or rheumatoid arthritis which persists beyond the usual course of disease of the injury that is the cause of the pain or more than 90 days after surgery. These standards include (but are not limited to):

n Having to complete a medical his-tory and physical prior to beginning treatment

n Requiring the patient to be seen at least every 3 months prior to contin-uation or modification of therapy.

This section of Florida law does not apply to prescribing practitioners who are:

n board certified anesthesiologists n physiatrists (spelling to be corrected

to “certified psychiatrist” during the 2012 session)

n neurologists n board certified physician with surgi-

cal privileges at a hospital or ambu-latory surgery center and primarily providing surgical services

n board certified medical specialist who has also completed a fellowship in pain medicine approved by the Accreditation Council for Graduate Medical Education or the American Osteopathic Association or

n board certified in pain medicine by a board approved by the American Board of Medical Specialties or the American Osteopathic Association and performs interventional pain of the the type routinely billed using surgical codes

so what does all this have to do with the practice of pharmacy?

In this new law there are conditions that must be met when patients are be-ing treated for pain with controlled substances by prescribers who do not hold the credentials listed above. The FPA questions whether it is possible for pharmacists to be aware of or know that those conditions have been met when presented with a prescription for pain medication. In some cases the pre-scribing practitioner’s credentials may not be readily available. We are also not sure how PBM auditors will rule on prescriptions that are not issued by pre-scribing practitioners under these new standards.

When will this requirement take effect?

F.S. 456.44 requires registration and designation of the physician as a con-trolled substance practitioner on their practitioner profile by January 1, 2012. You can view the physician’s profile by using the “Professional License Look-up” link on the home page of the FPA web site.

What about controlled substance prescriptions written by practitioners from other states?

We do not believe that the provisions of this law are applicable to out of state prescriptions as a physician licensed outside of Florida are not subject to Florida laws. Florida laws do however allow pharmacists to fill controlled sub-stance prescriptions from other states provided that the pharmacist called upon to fill such an order determines, in the exercise of his or her profession-al judgment, that the order was issued pursuant to a valid patient-physician re-lationship, that it is authentic, and that the drugs or medicinal supplies so or-dered are considered necessary for the continuation of treatment of a chronic or recurrent illness.

so what should a dispensing pharmacist do?

When a pharmacist receives a pre-scription and believes that it is for the treatment of chronic nonmalignant pain (CNP) and the pharmacist does not if the prescribing practitioner has been exempted from this new law then is recommended to circle back with the physician if the prescription and or its refills may last longer than 90 days. An inquiry should be made as to whether or not the patient has been seen within the last 3 months. This inquiry probably should be documented in the patient re-cord somewhere.

does this mean that a physician can no longer write for more than a 90-day supply of medications used to treat pain?

This change in Florida statutes 456 does not have language that specifi-cally mentions any prescribing limita-tions rather it places an obligation on physicians to evaluate a patient’s prog-ress “before” continuing treatment. It would appear to be prudent for the prescribing practitioner to order only a 90 day supply to ensure that patients whose prescriptions for chronic nonma-lignant pain has run out actually return to the office for a follow up visit and as-sessment if more medication is needed.

Editor’s note: Articles in this publication are designed to provide general information to FPA members. This information is pro-vided with the understanding that the Flor-ida Pharmacy Association is not engaged in rendering legal or other related professional services. If expert assistance or legal advice is required, the services of a competent pro-fessional should be sought.

new Law Impacts Treatment of Chronic nonmalignant Pain

18 | F l o r i d a P h a r m a c y T o d a y

aPha Foundation and nasPa bowl of hygeia

Awarded to a pharmacist for out-standing community service above and beyond professional duties. The use of the following selection criteria is re-quired:

n The recipient must be a Florida li-censed pharmacist and a member of FPA.

n The recipient must be living. Awards are not presented posthumously.

n The recipient has not previously re-ceived the award.

n The recipient is not currently serving nor has heshe served within the immediate past 2 years on its award committee or an officer of the asso-ciation in other than an ex officio ca-pacity.

n The recipient has compiled an out-standing record of community ser-vice, which, apart from hisher spe-cific identification as a pharmacist, reflects well on the profession.

James h. beal awardAwarded to the "Pharmacist of the

Year." The criteria established for this award is that the recipient be a Flori-da registered pharmacist and a mem-ber of FPA, who has rendered outstand-ing service to pharmacy within the past five years.Criteria:

n The recipient must be a Florida reg-istered pharmacist and a member of the FPA.

n The recipient has rendered outstand-ing service to pharmacy within the past five years.

Technician of the year awardAwarded annually to a Florida phar-

macy technician who is recognized for hisher outstanding performance and achievement during hisher career.

Criteria: n Candidate must be a member of the

Florida Pharmacy Association for at least 2 years.

n Candidate must have demonstrated contributions and dedication to the advancement of pharmacy techni-cian practice.

n Candidate must have demonstrated contributions to the Florida Pharma-cy Association andor other phar-macy organizations.

n Candidate must have demonstrated commitment to community service.

n Candidate is not a past recipient of this award.

r.Q. richards awardThis award is based on outstanding

achievement in the field of pharmaceu-tical public relations in Florida.Criteria:

n The recipient must be a Florida reg-istered pharmacist and a member of the FPA.

n The recipient has displayed out-standing achievement in the field of pharmaceutical public relations in Florida.

Frank Toback/aZO Consultant Pharmacist awardCriteria:

n Candidate must be an FPA member, registered with the Florida Board of Pharmacy as a consultant pharma-cist in good standing.

n Candidate should be selected based on their outstanding achievements in the field of consultant pharmacy.

dCPa sidney simkowitz Pharmacy involvement award

Presented annually to a Florida pharmacist who has been active at the local and state pharmacy association level in advancement of the profession of pharmacy in Florida.Criteria:

n A minimum of five years of active involvement in and contributions to the local association and FPA.

n Candidate must have held office at local level pharmacy association.

n Member in good standing for a pe-riod of at least five years in the FPA and must have served as a member or chairman of a committee of the association.

n Candidate must have been active-ly involved in a project that has or could potentially be of benefit to members of the profession.

Pharmacists mutual Companies distinguished young Pharmacist award

Awarded to a young pharmacist for their involvement and dedication to the practice of pharmacy.Criteria:

n Licensed to practice for nine (9) years or less.

n Licensed to practice in the state in which selected.

n Participation in national pharmacy association, professional programs, andor community service.

iPa roman maximo Corrons inspiration & motivation awardInteramerican Pharmacists Associa-tion created this award to honor the memory of Roman M. Corrons who in-spired and motivated countless phar-macists to participate actively and as-pire to take on leadership roles in their profession. Roman was always there with guidance and support that moti-vated pharmacists and encouraged vi-sionary leadership, approachable active membership and succession planning. This award recognizes the motivators among us who inspire others to contin-ue to advance the profession.Criteria:

n The recipient must be a Florida Li-censed Pharmacist and a member of the FPA.

n Candidate should motivate others to excel within the profession by en-couraging them to be leaders.

n Candidate is not necessarily an asso-ciation officer, but guides, supports andor inspires others.

A brief description on the candidate’s motivationalinspirational skills must accompany the nomination.

The Jean lamberti mentorship award

The Jean Lamberti Mentorship Award was established in 1998 to honor those pharmacists who have taken time to share their knowledge and experi-ence with pharmacist candidates. The award is named in honor of long time FPA member Jean Lamberti for her ef-fort in working with pharmacy stu-

c a l l F o r N o m i N a T i o N s F P a a W a r d s 2 0 1 1 - 2 0 1 2

o c T o B E r 2 0 1 1 | 19

dEadlinE FOr nOminaTiOns: FEbruary 28, 2012

dents.Criteria

n The recipient must be an FPA mem-ber.

n The recipient must serve as a role model for the profession of pharmacy.

upsher smith Excellence in innovation award

Awarded to honor practicing phar-macists who have demonstrated inno-vation in pharmacy practice that has re-sulted in improved patient care.Criteria:

n The recipient has demonstrated inno-vative pharmacy practice resulting in improved patient care.

n The recipient should be a practic-ing pharmacist within the geograph-ic area represented by the presenting Association.

Qualified Nominee: A pharmacist prac-

ticing within the geographic area repre-sented by the presenting Association.

Cardinal generation rx awardThe Cardinal Health Generation Rx

Champions Award recognizes a phar-macist who has demonstrated excellence in community-based prescription drug abuse prevention. The award is intend-ed to recognize outstanding efforts with-in the pharmacy community to raise awareness of this serious public health problem. It is also intended to encour-age educational prevention efforts aimed at patients, youth and other members of the community.

The nominee must be a pharmacist who is a member of the state association. Self-nominations are allowed. Applica-tions will be evaluated based upon the

following criteria: n Commitment to community-based

educational prevention efforts aimed at prescription drug abuse

n Involvement of other community groups in the planning and imple-mentation of prevention programs

n Innovation and creativity in the cre-ation and implementation of preven-tion activities

n Scopemagnitude of prescription drug abuse effortsDemonstrated impact of prescription

drug abuse prevention efforts

I AM PLEASED TO SUBMIT THE FOLLOWING NOMINATION:

Name:

Address:

FOR THE FOLLOWING AWARD:

(Nomination Deadline February 28, 2012)

APhA Foundation and NASPA Bowl of Hygeia

James H. Beal Award

R.Q. Richards Award

Frank Toback/AZO Consultant Pharmacist Award

DCPA Sydney Simkowitz Award

Pharmacists Mutual Co. Distinguished Young Pharmacist Award

Academy of Pharmacy Practice Practitioner Merit Award

The Jean Lamberti Mentorship Award

IPA Roman Maximo Corrons Inspiration & Motivation Award

Upsher Smith Excellence in Innovation Award

Technician of the Year Award

Cardinal Generation Rx Award

NOMINATED BY:

Name:

Date Submitted:

Signature:

Please describe briefly below the nominee's accomplishments, indicating why you feel he or she should receive this award. (Attach additional sheets if necessary.)

c a l l F o r N o m i N a T i o N s F P a a W a r d s 2 0 1 1 - 2 0 1 2

F P a a W a r d s n O m i n a T i O n F O r m

mail nominatons to: annual awards, Florida Pharmacy association, 610 n. adams st., tallahassee, Fl 32301(850) 222-2400 FaX (850) 561-6758 dEadlinE For nominations is FEBrUary 28, 2012

20 | F l o r i d a P h a r m a c y T o d a y

1986Twenty-five years ago:

n Food and Drug Administration approval of the first monoclonal antibody drug, Muronomab-CD3 (also known as Orthoclone OKT3), for treatment of transplant rejection

n Total health care expenses for a population of ap-proximately 244 million were approximately $477 billion.

n Average prescription price was $14.36 and the av-erage number of new and refill prescriptions filled per year was 29,100 according to the Lilly Digest.

Pharmacy Time Capsule 2011

By: Dennis B. Worthen Lloyd Scholar, Lloyd Library and Museum, Cincinnati, OHOne of a series contributed by the American Institute of the History of Pharmacy, a unique non-profit society dedicated to

assuring that the contributions of your profession endure as a part of America’s history. Membership offers the satisfaction of helping continue this work on behalf of pharmacy, and brings five or more historical publications to your door each year. To learn more, check out: www.aihp.org

1961Fifty years ago

n Pharmacist Donald Hedgpeth and the Northern Cal-ifornia Pharmaceutical Association indicted for vi-olation of the Sherman Anti-trust Act for the devel-opment of a pricing schedule that incorporated a professional fee.

n Amitriptyline HCl (Elavil) was introduced in the US by Merck Sharp & Dohme

n Total health care expenses for a population of approx-imately 189 million were approximately $29 billion.

n Average prescription price was $3.25 and the average number of new and refill prescriptions filled per year was 15,100 according to the Lilly Digest.

1936seventy-five year ago

n Johnstown, PA was hit with a devastating flood on St. Patrick’s Day. Initial reports were that 27 out of 34 drug stores were destroyed. Pharma-cists and manufacturers rushed aid to the city to assure that essential medicines were available.

1886One hundred twenty-five years ago

n The Brooklyn College of Pharmacy was formed in 1886. Renamed, it is now the Arnold and Marie Schwartz College of Pharmacy and Health Scienc-es of Long Island University.

o c T o B E r 2 0 1 1 | 21

CALL FOR RESOLuTIOnS TO THE 2012 HOuSE OF DELEGATES

The House of Delegates Board of Directors will meet in March 2012 to review and approve resolu-tions for the Annual Meeting. The deadline for submitting resolutions is March 15, 2012! PLEASE NOTE THIS DEADLINE.

The following information will be needed when submitting resolutions:

1. Name of organization: The name of the organization submitting the resolutions(s);2. Name and telephone number of individuals: A contact in the event clarification Or further in-

formation is needed; 3. Problem: A statement of the problem addressed by the resolution;4. Intent: A statement of what passage of the resolution will accomplish;5. Resolution Format: (please type and use double spacing)

title of resolution

nAme of orgAnizAtion

WHereAs , And

WHereAs :

tHerefore Be it

resolVed (tHAt tHe fpA or suBdiVision of fpA)

contAct nAme And pHone #:

proBlem:

intent:

Return this form to: Membership Coordinator, Florida Pharmacy Association, 610 North Adams Street, Tallahassee, Florida 32301 or fax (850) 561-6758

22 | F l o r i d a P h a r m a c y T o d a y

PharmaCy rEsOurCEs

AbbottDiabetes CareMichael J. Forker(239) 839-3313

Cerner EtrebyPharmacy Management Systems(800) 292-5590

PPSCRetail Pharmacy Purchasing Program(888) 778-9909

PharmaCy COnsulTanTs

HCC Pharmacy Business SolutionsDean Pedalino(800) 642-1652Mobile: (727) 460-1855

Empire Pharmacy ConsultantsMichael Chen PharmD., CPhPresidentCEO(786) 556-7825 Mobile (305) 374-1029 Office

lEgal assisTanCE

Kahan ◆ Shir, P.L.Brian A. Kahan, R.Ph., and Attorney at Law(561) 999-5999

PharmaCEuTiCal WhOlEsalEr

McKesson Drug CompanyJim Springer(800) 804-4590 FAX: (863) 616-2953

TEmPOrary PharmaCisTs –

sTaFFing

HealthCare Consultants Pharmacy StaffingBob Miller(800) 642-1652

Empire Pharmacy ConsultantsMichael Chen PharmD., CPhPresidentCEO(305) 374-1029 Office

Rx Relief(800) RXRELIEF

BuyEr’s GuidEADVERTISERS: This is a special section designed to give your company more exposure and to act as an easy reference for the pharmacist.

P H A R M A C Y T O D A Yflorida

advertising in Florida Pharmacy Todaydisplay advertising: please call (850) 264-5111 for a media kit and rate sheet. buyers’ guide: A signed insertion of at least 3X per year, 1/3 page or larger display ad, earns a placement in the Buyers’ Guide. A screened ad is furnished at additional cost to the advertiser. Professional referral ads: FPA Members: $50 per 50 words; Non-members: $100 per 50 words; No discounts for advertising agencies. All Professional Referral ads must be paid in advance, at the time of ad receipt.

AHCA MEDICAID PHARMACY SERVICES2727 Mahan DriveTallahassee, FL 32308(850) 487-4441www.fdhc.state.fl.usmedicaidpharmacy

AMERICAN PHARMACISTSASSOCIATION (APhA)Washington, D.C. (800) 237-2742www.pharmacist.com

AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTSBethesda, MD (301) 657-3000www.ashp.commain.htm

DRug INFORMATION CENTERPalm Beach Atlantic University(561) 803-2728druginfocenter@pba.edu

FLORIDA BOARD OF PHARMACY4052 Bald Cypress WayBin #C04Tallahassee, FL 32399-3254(850) 245-4292www.doh.state.fl.usmqa

FLORIDA POISON INFORMATION CENTER NETWORK(800) 222-1222www.fpicn.org

NATIONAL COMMuNITY PHARMACISTS ASSOCIATION 100 Daingerfield Road Alexandria, VA 22314703.683.8200703.683.3619 faxinfo@ncpanet.org

RECOVERINg PHARMACISTS NETWORK OF FLORIDA(407) 257-6606 “Pharmacists Helping Pharmacists”

FrEQuEnTly CallEd numbErs